TENOF-EM Tablet

Manufacturer
Hetero Labs Limited(INDIA)

Registraction Number
MAL16015041AZ

Content:
TENOF-EM tablets contain emtricitabine and tenofovir disoproxil fumarate. Each tablet typically contains 200 mg of emtricitabine and 300 mg of tenofovir disoproxil fumarate.
Indications:

• HIV-1 Treatment: Used in combination with other antiretroviral agents for the treatment of HIV-1 infection in adults.
• Pre-Exposure Prophylaxis (PrEP): Used in combination with safer sex practices to reduce the risk of sexually acquired HIV-1 infection in adults.

1. Dosage: One tablet daily, with or without food.
2. Consistency: Take the tablet at the same time each day.
3. Adherence: Do not miss doses, as this can increase the risk of HIV infection.
4. Monitoring: Regular HIV-1 testing and monitoring for side effects are recommended.